Tissue-resident microbiota impacts colorectal cancer progression and prognosisBGI Genomics, Shenzhen, China.
BGI Genomics, Shenzhen, China.
BGI Genomics, Shenzhen, China.
Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
College of Life Sciences, University of Chinese Academy of Sciences, Beijing, China.
BGI Genomics, Shenzhen, China.
BGI Genomics, Shenzhen, China; BGI Precision Nutrition, Shenzhen, China.
Science for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Stockholm, Sweden; Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
BGI Genomics, Shenzhen, China.
Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
BGI Genomics, Shenzhen, China; BGI Precision Nutrition, Shenzhen, China.
Show others and affiliations
2026 (English)In: Nature Communications, E-ISSN 2041-1723, Vol. 17, no 1, article id 346Article in journal (Refereed) Published
Abstract [en]
To deepen the understanding of tissue-resident microbiota in colorectal cancer (CRC), we analyzed whole-genome and transcriptome data from 937 patients. We identified 249 genera and 361 species commonly present in both tumors and adjacent normal tissues (NATs). Distinct microbial signatures were associated with anatomical location, tumor stages, hypermutation status, mutations in CRC driver and DNA damage repair genes, as well as consensus molecular subtypes (CMSs). Notably, the presence of the pks island and elevated abundance of Enterobacteriaceae were linked to poor prognosis specifically in CMS2 tumors. Finally, microbial risk scores derived from taxa present in tumor or NATs predicted patient prognosis independently of established clinico-molecular factors. Prognostic taxa were strongly associated with tumor transcriptomic pathways related to hypoxia, immune response, and metabolic status. These findings revealed the heterogeneity of tissue-resident microbiota and their critical role in CRC progression, highlighting potential avenues for targeted intervention.
Place, publisher, year, edition, pages
Nature Publishing Group, 2026. Vol. 17, no 1, article id 346
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:umu:diva-249024DOI: 10.1038/s41467-025-67047-2ISI: 001658014000002PubMedID: 41354681Scopus ID: 2-s2.0-105027014005OAI: oai:DiVA.org:umu-249024DiVA, id: diva2:2032691
2026-01-272026-01-272026-01-27Bibliographically approved